Drug Trial Radar · NCT00545753
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
Last checked: Nov 20, 2026Latest source record: Oct 11, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
558
Actual
Start
Sep 2007
Primary completion
Mar 2008
Study completion May 2008
Sponsor
- Lead sponsor
- ParaPRO LLCIndustry
- Sponsor type
- Industry
- First posted
- Oct 17, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pediculosis capitis (human head lice).
Conditions
- Pediculosis
Interventions
SpinosadDrug
10 minute topical application product, following by a complete rinse off.
SpinosadDrug
10 minute topical application followed by a complete rinse off, followed by a nit combing regimen
Permethrin 1%Drug
Topical application for 10 minutes, followed by a complete rinse off, followed by a nit combing regimen
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of NatrOVA Creme Rinse - 1% Relative to NIX Creme Rinse in Subjects Infested With Head LiceTime frame: Assessment were made 14 days following the final product treatment
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Hill Top Research
Scottsdale, Arizona
Burke Pharmaceutical Research
Hot Springs, Arkansas
Impact Clinical Trials
Beverly Hills, California
DMI Healthcare Group
Largo, Florida
Hill Top Research
Miamiville, Ohio
Haber Dermatology & Cosmetic Surgery
South Euclid, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.